|1|Novel Immunotherapies for B-Cell Lymphomas and Leukemias. (25237982)
Tees M.T.... Sokol L.
|2|Nodal involvement by marginal zone B-cell lymphoma harboring t(14;22)(q32;q11) involving immunoglobulin heavy chain and light chain lambda as the sole karyotypically recognizable abnormality in a patient with systemic lupus erythematosus. (25197401)
Li K.... Wang H.Y.
|3|Influence of polymorphisms in ERCC5, XPA and MTR DNA repair and synthesis genes in B-cell lymphoma risk. A case-control study in Spanish population. (23818366)
Ruiz-Cosano J.... Conesa-Zamora P.
|4|Primary mediastinal large B-cell lymphoma segregating in a family: exome sequencing identifies MLL as a candidate predisposition gene. (23457195)
Saarinen S.... Aaltonen L.A.
|5|Karyotyping of diffuse large B-cell lymphomas: loss of 17p is associated with poor patient outcome. (23859481)
Fiskvik I.... Holte H.
|6|Activation of the STAT3 Signaling Pathway Is Associated With Poor Survival in Diffuse Large B-Cell Lymphoma Treated With R-CHOP. (24220563)
Huang X.... Fu K.
|7|Infusion Rate Escalation Study of Rituximab in Patients with CD20+ B-Cell Lymphomas: A Single Institution Analysis in Japan. (23691364)
Yokoyama M.... Hatake K.
|8|Paradoxical Regulation of Hypoxia Inducible Factor-1I+ (HIF-1I+) by Histone Deacetylase Inhibitor in Diffuse Large B-Cell Lymphoma. (24312289)
Bhalla S.... Gordon L.I.
|9|MicroRNAs as prognostic markers in indolent primary cutaneous B-cell lymphoma. (22936066)
MonsA!lvez V.... OrtA-z-Romero P.L.
|10|An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and I9SUVmax. (23649463)
Itti E.... Haioun C.
|11|Pediatric Burkitt's Lymphoma and Diffuse B-Cell Lymphoma: Are Surveillance Scans Required? (24087880)
Eissa H.M.... Bollard C.M.
|12|Two Cases of Diffuse Large B-Cell Lymphomas in the Cervical Lymph Nodes in Patients with Low-Grade Gastric Marginal Zone B-Cell Lymphoma (MALT Lymphoma). (23767042)
Jung J.H.... Kim J.H.
|13|Massive transcriptional perturbation in subgroups of diffuse large B-cell lymphomas. (24223701)
Rosolowski M.... Loeffler M.
|14|Lenalidomide in diffuse large B-cell lymphomas. (22792112)
Chiappella A.... Vitolo U.
|15|A case of monoclonal gammopathy in extranodal marginal zone B-cell lymphoma of the small intestine. (21239866)
Kim d.o. .Y.... Chae S.L.
|16|Treatment of patients with refractory diffuse large B-cell lymphoma or mantle cell lymphoma with alemtuzumab, alone or in combination with cytotoxic chemotherapy. (21067447)
Yi J.H.... Kim W.S.
|17|A fatal case of hemoperitoneum after ultrasound-guided liver biopsy in a patient with intravascular large B-cell lymphoma. (21377915)
Aoki Y.... Maeno Y.
|18|FOXP1 molecular cytogenetics and protein expression analyses in primary cutaneous large B cell lymphoma, leg-type. (21154235)
Espinet B.... SolAc F.
|19|Critical role of PI3K signaling for NF-kappaB-dependent survival in a subset of activated B-cell-like diffuse large B-cell lymphoma cells. (21173233)
Kloo B.... Krappmann D.
|20|Molecular characterization of 9p21 deletions shows a minimal common deleted region removing CDKN2A exon 1 and CDKN2B exon 2 in diffuse large B-cell lymphomas. (21638516)
Guney S.... Bastard C.
|21|Pulmonary marginal zone B-cell lymphoma of MALT type--what is a prognostic factor and which is the optimal treatment, operation, or chemotherapy?: Consortium for Improving Survival of Lymphoma (CISL) study. (20024551)
Oh S.Y.... Kim H.J.
|22|18F-FDG PET/CT in a case of intravascular large B-cell lymphoma. (20607536)
Sanli Y.... Adalet I.
|23|Epigenetic down-regulation of the tumor suppressor gene PRDM1/Blimp-1 in diffuse large B cell lymphomas: a potential role of the microRNA let-7. (20651244)
Nie K.... Tam W.
|24|A rare reason of foot drop caused by primary diffuse large b-cell lymphoma of the sciatic nerve: case report. (19415174)
Kahraman S.... Sirin S.
|25|A novel flow cytometric antibody panel for distinguishing Burkitt lymphoma from CD10+ diffuse large B-cell lymphoma. (20395518)
Schniederjan S.D.... Mann K.P.
|26|Retreatment with rituximab in 178 patients with relapsed and refractory B-cell lymphomas: a single institution case control study. (20038227)
Johnston A.... Coiffier B.
|27|Most primary central nervous system diffuse large B-cell lymphomas occurring in immunocompetent individuals belong to the nongerminal center subtype: a retrospective analysis of 31 cases. (19935644)
Hattab E.M.... Al-Abbadi M.A.
|28|Caspase 3a: new prognostic marker for diffuse large B-cell lymphoma in the rituximab era. (20919853)
Provencio M.... Bellas C.
|29|Nuclear expression of YB-1 in diffuse large B-cell lymphoma: correlation with disease activity and patient outcome. (19500133)
Xu W.... Shen H.
|30|BCL2 expression in de novo diffuse large B-cell lymphoma partly reflects normal differences in age distribution. (19508293)
Thunberg U.... Berglund M.
|31|Small-molecule XIAP antagonist restores caspase-9 mediated apoptosis in XIAP-positive diffuse large B-cell lymphoma cells. (17916749)
Cillessen S.A.... Oudejans J.J.
|32|Prognostic significance of aberrant promoter hypermethylation of CpG islands in patients with diffuse large B-cell lymphomas. (18539616)
Amara K.... Korbi S.
|33|Expression of TNF-receptor associated factor 2 correlates with poor progression-free survival time in ABC-like primary nodal diffuse large B-cell lymphomas. (18312353)
van Galen J.C.... Oudejans J.J.
|34|Nuclear CD40 interacts with c-Rel and enhances proliferation in aggressive B-cell lymphoma. (17567982)
Zhou H.J.... Ford R.J.
|35|Comparison of ataxia-telangiectasia mutated protein expression in diffuse large B-cell lymphomas of primary central nervous system and non-central nervous system origin. (17516749)
Kim S.H.... Yang W.I.
|36|Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas. (16424392)
Tam W.... Knowles D.M.
|37|Constitutive NF-kappaB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas. (16497967)
Fu L.... Ford R.J.
|38|CD5-positive diffuse large B-cell lymphoma with an unusual phenotype: Cytoplasmic CD20 (+), surface CD20 (-). (16923582)
Yokose N.... Dan K.
|39|Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue arising in the lateral ventricle. (16194887)
Kelley T.W.... Hsi E.D.
|40|Coexistent rearrangements of c-MYC, BCL2, and BCL6 genes in a diffuse large B-cell lymphoma. (14979479)
Ueda C.... Ohno H.
|41|Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas. (15377470)
Malpeli G.... Menestrina F.
|42|Mutations of the BIK gene in human peripheral B-cell lymphomas. (12874789)
Arena V.... Larocca L.M.
|43|Alpha-2,6-sialylation of L-PHA reactive oligosaccharides and expression of N-acetylglucosaminyltransferase V in human diffuse large B cell lymphoma. (14534692)
Suzuki O.... Abe M.
|44|Pathobiology of primary mediastinal B-cell lymphoma. (15202521)
Pileri S.A.... Cavalli F.
|45|Plasma exchange and continuous hemodiafiltration as an initial treatment for diffuse large B-cell lymphoma-associated hemophagocytic syndrome]. (11868363)
Yanagiya N.... Miura I.
|46|Role of radiation therapy in the management of primary mediastinal large B-cell lymphoma (PMLBL). (12553345)
Itami J.... Saito K.
|47|Somatically mutated regions of immunoglobulin on human B-cell lymphomas code for peptides that bind to autologous major histocompatibility complex class I, providing a potential target for cytotoxic T cells. (11431353)
Gricks C.S.... Amlot P.L.
|48|A reassessment of primary thyroid lymphoma: high-grade MALT-type lymphoma as a distinct subtype of diffuse large B-cell lymphoma. (10931213)
Skacel M.... Hsi E.D.
|49|Cerebral B-cell lymphoma following treatment for Tolosa-Hunt syndrome. (10192704)
Takao T.... Iwaki T.
|50|Splenic marginal zone lymphoma: a distinctive type of low-grade B-cell lymphoma. A clinicopathological study of 13 cases. (7573673)
Mollejo M.... Piris M.A.